Literature DB >> 9258964

Ocular abnormalities in Down syndrome: an analysis of 140 Chinese children.

V Wong1, D Ho.   

Abstract

One hundred forty Chinese children with Down syndrome (DS) treated in the Child Assessment Centre of the Duchess of Kent Children's Hospital in Hong Kong between 1985 and 1996 underwent a detailed ophthalmologic evaluation, including test of visual acuity by behavioral testing or retinoscopy, determination of ocular motility, visual field examination, binocular examination for strabismus, determination of near point convergence and pupillary reflex, and/or slit lamp bimicroscopy and ophthalmoscopy to assess ocular health. Only 43 children (31%) had no ocular abnormalities. The overall incidence of ocular abnormalities was 69%, and included refractive error (58%), strabismus (20%), nystagmus (11%), blepharitis/conjunctivitis (7%), lens opacities (4%), and glaucoma (0.7%). No child had Brushfield spots or keratoconus. The incidence of refractive errors increased with increasing age and nearly doubled at school age. As compared with white children with DS, the Chinese children with DS exhibited a higher incidence of refractive error and a similar incidence of lens opacities but a lower incidence of strabismus, nystagmus, blepharitis, Brushfield spots, and keratoconus. Regular visual surveillance, especially of visual acuity, in children with DS as they mature is important in preventing amblyopia.

Entities:  

Mesh:

Year:  1997        PMID: 9258964     DOI: 10.1016/s0887-8994(97)00029-5

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  13 in total

1.  The Down syndrome critical region regulates retinogeniculate refinement.

Authors:  Martina Blank; Peter G Fuerst; Beth Stevens; Navid Nouri; Lowry Kirkby; Deepti Warrier; Ben A Barres; Marla B Feller; Andrew D Huberman; Robert W Burgess; Craig C Garner
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

2.  Visual characteristics of children with Down syndrome.

Authors:  Kaoru Tomita
Journal:  Jpn J Ophthalmol       Date:  2017-02-07       Impact factor: 2.447

3.  The accuracy of photoscreening at detecting treatable ocular conditions in children with Down syndrome.

Authors:  Tammy Yanovitch; David K Wallace; Sharon F Freedman; Laura B Enyedi; Priya Kishnani; Gordon Worley; Blythe Crissman; Erica Burner; Terri L Young
Journal:  J AAPOS       Date:  2010-12       Impact factor: 1.220

4.  An assessment of optokinetic nystagmus (OKN) in persons with Down syndrome.

Authors:  Alberto C S Costa
Journal:  Exp Brain Res       Date:  2011-08-14       Impact factor: 1.972

5.  Refractive errors and ocular findings in children with intellectual disability: a controlled study.

Authors:  Arsen Akinci; Ozgur Oner; Ozlem Hekim Bozkurt; Alev Guven; Aydan Degerliyurt; Kerim Munir
Journal:  J AAPOS       Date:  2008-07-02       Impact factor: 1.220

6.  Refractive errors and strabismus in children with Ddown syndrome: a controlled study.

Authors:  Arsen Akinci; Ozgur Oner; Ozlem Hekim Bozkurt; Alev Guven; Aydan Degerliyurt; Kerim Munir
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2009 Mar-Apr       Impact factor: 1.402

Review 7.  Clinical practice. The care of children with Down syndrome.

Authors:  Michel E Weijerman; J Peter de Winter
Journal:  Eur J Pediatr       Date:  2010-07-15       Impact factor: 3.183

8.  Ocular findings in Japanese children with Down syndrome: the course of visual acuity and refraction, and systemic and ocular anomalies.

Authors:  Tomoko Terai; Shohei Eda; Jun Sugasawa; Masahiro Tonari; Junko Matsuo; Hidehiro Oku; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2018-08-31

9.  Refractive errors and strabismus in Down's syndrome in Korea.

Authors:  Dae Heon Han; Kyun Hyung Kim; Hae Jung Paik
Journal:  Korean J Ophthalmol       Date:  2012-11-12

10.  Effects of bifocals on visual acuity in children with Down syndrome: a randomized controlled trial.

Authors:  Christine de Weger; Nienke Boonstra; Jeroen Goossens
Journal:  Acta Ophthalmol       Date:  2018-10-27       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.